Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82 (11): 844–851.
2. Ferris III FL, Fine SL, Hyman L . Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102 (11): 1640–1642.
3. Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES et al. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Arch Ophthalmol 2002; 120 (11): 1443–1454.
4. Novartis. Verteporfin prescribing information. (accessed 17 May 2009 at
http://www.visudyne.com/assets/pdf/PI.pdf
). 2001.
5. Gilead. Macugen prescribing information. (accessed 18 May 2010 at
http://www.macugen.com/macugenUSPI.pdf
). 2004.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献